Perspective Therapeutics (CATX) Assets Average (2011 - 2026)

Perspective Therapeutics (CATX) has 15 years of Assets Average data on file, last reported at $338.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 1.09% year-over-year to $338.9 million; the trailing twelve-month figure through Mar 2026 stood at $338.9 million (up 1.09% YoY), and the FY2025 full-year result was $304.0 million, up 38.52% from the prior year.
• Assets Average climbed to $338.9 million in Q1 2026, from $280.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $388.5 million in Q3 2024 to a low of $60.3 million in Q4 2022.
• A 5-year average of $208.5 million and a median of $188.1 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 251.35% in 2024 and slipped 23.28% in 2025, its largest moves.
• Tracing CATX's Assets Average over 5 years: stood at $60.3 million in 2022, then surged by 72.77% to $104.2 million in 2023, then soared by 251.35% to $366.1 million in 2024, then declined by 23.28% to $280.9 million in 2025, then gained by 20.64% to $338.9 million in 2026.
• Business Quant data shows CATX's Assets Average at $338.9 million in Q1 2026, $280.9 million in Q4 2025, and $302.8 million in Q3 2025.